BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 19918748)

  • 1. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
    Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
    G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
    Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
    J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of focal segmental glomerulosclerosis: new insights.
    D'Agati VD
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):271-81. PubMed ID: 18408478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of disease: focal segmental glomerulosclerosis.
    Meyrier A
    Nat Clin Pract Nephrol; 2005 Nov; 1(1):44-54. PubMed ID: 16932363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal segmental glomerulosclerosis and renal transplantation.
    Crosson JT
    Transplant Proc; 2007 Apr; 39(3):737-43. PubMed ID: 17445586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.
    Wharram BL; Goyal M; Wiggins JE; Sanden SK; Hussain S; Filipiak WE; Saunders TL; Dysko RC; Kohno K; Holzman LB; Wiggins RC
    J Am Soc Nephrol; 2005 Oct; 16(10):2941-52. PubMed ID: 16107576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of podocytes in glomerular pathobiology.
    Asanuma K; Mundel P
    Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of podocyte injury in chronic kidney disease].
    Asanuma K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
    Lee HS; Song CY
    Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of podocyte phenotype in collapsing glomerulopathies.
    Barisoni L; Kopp JB
    Microsc Res Tech; 2002 May; 57(4):254-62. PubMed ID: 12012394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of podocyte damage in the pathogenesis of glomerulosclerosis and tubulointerstitial lesions: findings in the growth hormone transgenic mouse model of progressive nephropathy].
    Wanke R; Wolf E; Brem G; Hermanns W
    Verh Dtsch Ges Pathol; 2001; 85():250-6. PubMed ID: 11894406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting podocyte-associated diseases.
    Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.
    Schwartz MM
    Ren Fail; 2000 Nov; 22(6):663-84. PubMed ID: 11104157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of podocytes in proteinuria.
    Asanuma K; Yanagida-Asanuma E; Takagi M; Kodama F; Tomino Y
    Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S15-20. PubMed ID: 17995522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis.
    Zuo Y; Matsusaka T; Zhong J; Ma J; Ma LJ; Hanna Z; Jolicoeur P; Fogo AB; Ichikawa I
    J Am Soc Nephrol; 2006 Oct; 17(10):2832-43. PubMed ID: 16988066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The podocyte's response to injury: role in proteinuria and glomerulosclerosis.
    Shankland SJ
    Kidney Int; 2006 Jun; 69(12):2131-47. PubMed ID: 16688120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal segmental glomerulosclerosis: recent advances.
    Pollak MR
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):138-42. PubMed ID: 18277145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.